{"DataElement":{"publicId":"10401736","version":"1","preferredName":"Disease Response Domain Leukemia Response status","preferredDefinition":"The overall disease response status to treatment of Leukemia.","longName":"RS_RSORRES_OVRLRES","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7050204","version":"1","preferredName":"Disease Response Domain Leukemia Molecular Response","preferredDefinition":"A domain for disease response evaluations._A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years._An evaluation of the molecular response of the disease to the therapy.","longName":"6608777v1.0:7050202v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6608777","version":"1","preferredName":"Disease Response Domain","preferredDefinition":"A domain for disease response evaluations.","longName":"C107097","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response Domain","conceptCode":"C107097","definition":"A domain for disease response evaluations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6DD03A-0CB9-71AE-E053-F662850AB42C","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7050202","version":"1","preferredName":"Leukemia Molecular Response","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.:An evaluation of the molecular response of the disease to the therapy.","longName":"C3161:C123624","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Molecular Response","conceptCode":"C123624","definition":"An evaluation of the molecular response of the disease to the therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96DD16AA-085E-3A1D-E053-F662850A752E","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"96DD16AA-086F-3A1D-E053-F662850A752E","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-08","modifiedBy":"KUMMEROA","dateModified":"2020-06-18","changeDescription":"Released. AK 2020-6-10; Created for CDSIC aligned NCI Standard CRFs. ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"10392505","version":"1","preferredName":"Disease Response Status","preferredDefinition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._A condition or state at a particular time.","longName":"10392505v1.00","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Complete Remission (CR)","valueDescription":null,"ValueMeaning":{"publicId":"3091615","version":"1","preferredName":"Complete Remission","longName":"3091615","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87290F15-975A-7CF7-E040-BB89AD433E33","latestVersionIndicator":"Yes","beginDate":"2010-05-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-05-22","modifiedBy":"KUMMEROA","dateModified":"2023-03-22","changeDescription":null,"administrativeNotes":"2023.3.22 Alt VM added per ticket request CADSR0002191. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC126EC-1D96-3073-E053-731AD00A1C5A","beginDate":"2022-06-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-06-01","modifiedBy":"MMADDINENI","dateModified":"2022-06-01","deletedIndicator":"No"},{"value":"CR With Partial Recovery of Platelet Count (CRp)","valueDescription":null,"ValueMeaning":{"publicId":"4639742","version":"1","preferredName":"Complete Response with Incomplete Platelet Recovery","longName":"4639742","preferredDefinition":"The disappearance of all signs of cancer in response to treatment, accompanied by incomplete platelet recovery (platelet count is less than 100,000/uL).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Response with Incomplete Platelet Recovery","conceptCode":"C118794","definition":"The disappearance of all signs of cancer in response to treatment, accompanied by incomplete platelet recovery (platelet count is less than 100,000/uL).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A711901-5A69-D5F1-E050-BB89AD431F21","latestVersionIndicator":"Yes","beginDate":"2014-12-17","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-12-17","modifiedBy":"KUMMEROA","dateModified":"2023-03-22","changeDescription":null,"administrativeNotes":"2023.3.22 Alt VM added per ticket request CADSR0002191. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC126EC-1D97-3073-E053-731AD00A1C5A","beginDate":"2022-06-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-06-01","modifiedBy":"MMADDINENI","dateModified":"2022-06-01","deletedIndicator":"No"},{"value":"CR with incomplete blood count recovery (CRi)","valueDescription":null,"ValueMeaning":{"publicId":"6674540","version":"1","preferredName":"Complete Response with Incomplete Bone Marrow Recovery","longName":"6674540","preferredDefinition":"The disappearance of all signs of cancer in response to treatment accompanied by incomplete bone marrow recovery, as evidenced by persistent anemia, thrombocytopenia or neutropenia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Response with Incomplete Bone Marrow Recovery","conceptCode":"C103385","definition":"The disappearance of all signs of cancer in response to treatment accompanied by incomplete bone marrow recovery, as evidenced by persistent anemia, thrombocytopenia or neutropenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83E8FF08-E035-1D09-E053-F662850ACD4A","latestVersionIndicator":"Yes","beginDate":"2019-03-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-12","modifiedBy":"MMADDINENI","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":"2023.3.22 Alt VM added per ticket request CADSR0002191. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC126EC-1D98-3073-E053-731AD00A1C5A","beginDate":"2022-06-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-06-01","modifiedBy":"MMADDINENI","dateModified":"2022-06-07","deletedIndicator":"No"},{"value":"Aplasia","valueDescription":null,"ValueMeaning":{"publicId":"10392539","version":"1","preferredName":"Aplasia/Hypoplasia","longName":"10392539v1.00","preferredDefinition":"A finding that generally has features of aplasia and hypoplasia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aplasia/Hypoplasia","conceptCode":"C163720","definition":"A finding that generally has features of aplasia and hypoplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC126EC-1D95-3073-E053-731AD00A1C5A","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-06-01","modifiedBy":"MMADDINENI","dateModified":"2022-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC126EC-1D99-3073-E053-731AD00A1C5A","beginDate":"2022-06-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-06-01","modifiedBy":"MMADDINENI","dateModified":"2022-06-01","deletedIndicator":"No"},{"value":"MRD negative","valueDescription":null,"ValueMeaning":{"publicId":"5654916","version":"1","preferredName":"Minimal Residual Disease Negativity","longName":"5654916","preferredDefinition":"Absence of residual disease based on laboratory techniques.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Residual Disease Negativity","conceptCode":"C124428","definition":"Absence of residual disease based on laboratory techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"47E1D321-5203-5A79-E053-F662850A5552","latestVersionIndicator":"Yes","beginDate":"2017-02-06","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-02-06","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC126EC-1D9A-3073-E053-731AD00A1C5A","beginDate":"2022-06-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-06-01","modifiedBy":"MMADDINENI","dateModified":"2022-06-01","deletedIndicator":"No"},{"value":"Treatment Failure","valueDescription":null,"ValueMeaning":{"publicId":"2578570","version":"1","preferredName":"Lack of Efficacy","longName":"2578570","preferredDefinition":"The lack of expected or desired effect related to a therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lack of Efficacy","conceptCode":"C48226","definition":"The lack of expected or desired effect related to a therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FFF7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-06","modifiedBy":"KUMMEROA","dateModified":"2023-03-22","changeDescription":null,"administrativeNotes":"2023.3.22 Alt VM added per ticket request CADSR0002191. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC126EC-1D9B-3073-E053-731AD00A1C5A","beginDate":"2022-06-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-06-01","modifiedBy":"MMADDINENI","dateModified":"2022-06-01","deletedIndicator":"No"},{"value":"Relapse","valueDescription":null,"ValueMeaning":{"publicId":"3828963","version":"1","preferredName":"Recurrent Disease","longName":"3828963","preferredDefinition":"The return of a disease after a period of remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2A8BB67-2BCE-B6D0-E040-BB89AD43093C","latestVersionIndicator":"Yes","beginDate":"2013-07-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"SOKKERL","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":"2023.1.20 Alt VM added per ticket request CADSR0001943. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC126EC-1D9C-3073-E053-731AD00A1C5A","beginDate":"2022-06-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-06-01","modifiedBy":"MMADDINENI","dateModified":"2022-06-01","deletedIndicator":"No"},{"value":"Aplasia","valueDescription":null,"ValueMeaning":{"publicId":"7640819","version":"1","preferredName":"Agenesis","longName":"7640819v1.00","preferredDefinition":"A congenital abnormality resulting in the absence of an anatomical structure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agenesis","conceptCode":"C120864","definition":"A congenital abnormality resulting in the absence of an anatomical structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0AB081F-E7AD-58AD-E053-4EBD850A10B7","latestVersionIndicator":"Yes","beginDate":"2021-04-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-04-23","modifiedBy":"GDEEN","dateModified":"2023-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F89DDAE1-538D-1F9E-E053-731AD00A33CE","beginDate":"2023-04-05","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-04-05","modifiedBy":"GDEEN","dateModified":"2023-04-05","deletedIndicator":"No"},{"value":"Inevaluable","valueDescription":null,"ValueMeaning":{"publicId":"2568561","version":"1","preferredName":"inevaluable","longName":"2568561","preferredDefinition":"inevaluable","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D8DE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-24","modifiedBy":"KUMMEROA","dateModified":"2023-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F8B14E93-751D-1C02-E053-731AD00A3415","beginDate":"2023-04-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-06","modifiedBy":"KUMMEROA","dateModified":"2023-04-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6612626","version":"1","preferredName":"Disease Response Status","preferredDefinition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.:A condition or state at a particular time.","longName":"C50995:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F861447-6ADE-182F-E053-F662850A17F5","latestVersionIndicator":"Yes","beginDate":"2019-01-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC126EC-1D94-3073-E053-731AD00A1C5A","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2023-04-06","changeDescription":null,"administrativeNotes":"2023.4.6 Added PV per Marie email. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"RS_RSORRES_BESTRESP","type":"COG Form Element","context":"COG"}],"ReferenceDocuments":[{"name":"What was the overall response?","type":"Preferred Question Text","description":"What was the overall response?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Patient's best overall response:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-B621-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-06-01","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-06-01","modifiedBy":"KUMMEROA","dateModified":"2023-04-05","changeDescription":null,"administrativeNotes":"2023.4.5 AQT/Alt SN added per ticket request CADSR0002275. ak","unresolvedIssues":null,"deletedIndicator":"No"}}